PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy
Jianbiao Zhou(National University Cancer Institute, Singapore), Chien Shing Chen(Loma Linda University)
Cited by 65
Related Papers
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
|Blood|2011|212
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
|Journal of Hematology & Oncology|2017|75
A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
|Journal of Hematology & Oncology|2018|39
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma
|Molecular Cancer|2023|36